PWPeter Woulfe

Peter Woulfe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peter Woulfe has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A 16-sensor prototype for brachytherapy in vivo dosimetry characterization

    by Agnese Giaz, Marco Galoppo, Nikolay Ampilogov, Simona Cometti, Sergio Esteve, Jennifer Hanly, Orla Houlihan, Wern Kam, Micheal Martyn, Owen McLaughlin, et al.

    The ORIGIN project (Optical Fiber Dose Imaging for Adaptive Brachytherapy) targets the production and qualification of a real-time radiation dose imaging and source localization system for both Low Dose Rate and High Dose Rate brachytherapy treatments. This goal will be achieved through a 16-fibre sensor system. Each fibre tip has been engineered to house a small volume of scintillating material to allow for measurements of the delivered dose. The instrument is based on Silicon Photomultipliers detectors, with a solution fully qualified on a single fibre prototype and currently being scaled up through the use of the CITIROC1A ASIC by WEEROC, embedded in the FERS-DT5202 scalable platform designed by CAEN S.p.A. The key features for a system such as ORIGIN, which aims to perform dose measurements in a clinical environment, are fibre response uniformity, system stability, high sensitivity, and perfect reproducibility. The commissioning of the 16-channel dosimeter system in laboratory conditions, with an X-ray cabinet, demonstrated reproducibility of measurements with deviations below 1% after the equalization procedure of the 16 sensors. Finally, the system performance, evaluated in clinical conditions (High Dose Rate centre, Belfast Hospital), allowed for valuable insight into the possible systematics which are present in the current system while simultaneously corroborating the validity of the equalization procedure.


  • Open Access

    Quantifying Tumor Heterogeneity from Multiparametric Magnetic Resonance Imaging of Prostate Using Texture Analysis

    by Saleh T. Alanezi, Frank Sullivan, Christoph Kleefeld, John F. Greally, Marcin J. Kraśny, Peter Woulfe, Declan Sheppard, Niall Colgan

    (1) Background: Multiparametric MRI (mp-MRI) is used to manage patients with PCa. Tumor identification via irregular sampling or biopsy is problematic and does not allow the comprehensive detection of the phenotypic and genetic alterations in a tumor. A non-invasive technique to clinically assess tumor heterogeneity is also in demand. We aimed to identify tumor heterogeneity from multiparametric magnetic resonance images using texture analysis (TA). (2) Methods: Eighteen patients with prostate cancer underwent mp-MRI scans before prostatectomy. A single radiologist matched the histopathology report to single axial slices that best depicted tumor and non-tumor regions to generate regions of interest (ROIs). First-order statistics based on the histogram analysis, including skewness, kurtosis, and entropy, were used to quantify tumor heterogeneity. We compared non-tumor regions with significant tumors, employing the two-tailed Mann–Whitney U test. Analysis of the area under the receiver operating characteristic curve (ROC-AUC) was used to determine diagnostic accuracy. (3) Results: ADC skewness for a 6 × 6 px filter was significantly lower with an ROC-AUC of 0.82 (p = 0.001). The skewness of the ADC for a 9 × 9 px filter had the second-highest result, with an ROC-AUC of 0.66; however, this was not statistically significant (p = 0.08). Furthermore, there were no substantial distinctions between pixel filter size groups from the histogram analysis, including entropy and kurtosis. (4) Conclusions: For all filter sizes, there was poor performance in terms of entropy and kurtosis histogram analyses for cancer diagnosis. Significant prostate cancer may be distinguished using a textural feature derived from ADC skewness with a 6 × 6 px filter size.


  • Open Access

    Dosimetric Application of Phosphorus Doped Fibre for X-ray and Proton Therapy

    by Olugbenga J. Olusoji, Crystal Penner, Camille Bélanger-Champagne, Wern Kam, Michael Martyn, Peter Woulfe, Cornelia Hoehr, Sinead O’keeffe

    Phosphorous-doped silica optical fibres with a core diameter of 4 µm were tested in X-ray and proton fields for application in cancer therapy dosimetry. Specifically, the radiation-induced attenuation was investigated in terms of linearity in deposited dose in 15 MV and 6 MV photons and 74 MeV protons, as well as Bragg-peak detection along the proton track. Fibres were found to demonstrate linear relative dose response in both radiation modalities, but possible saturation did occur at the high linear energy transfer of the Bragg peak. This demonstrates the possibility to use these fibres as a relative dosimeter for radiation therapy applications.


  • Open Access

    Optical fibre based real-time measurements during an LDR prostate brachytherapy implant simulation: using a 3D printed anthropomorphic phantom

    by P. Woulfe, F. J. Sullivan, L. Byrne, A. J. Doyle, W. Kam, M. Martyn, S. O’kEeffe

    An optical fibre sensor based on radioluminescence, using the scintillation material terbium doped gadolinium oxysulphide (Gd2O2S:Tb) is evaluated, using a 3D printed anthropomorphic phantom for applications in low dose-rate (LDR) prostate brachytherapy. The scintillation material is embedded in a 700 µm diameter cavity within a 1 mm plastic optical fibre that is fixed within a brachytherapy needle. The high spatial resolution dosimeter is used to measure the dose contribution from Iodine-125 (I-125) seeds. Initially, the effects of sterilisation on the sensors (1) repeatability, (2) response as a function of angle, and (3) response as a function of distance, are evaluated in a custom polymethyl methacrylate phantom. Results obtained in this study demonstrate that the output response of the sensor, pre- and post-sterilisation are within the acceptable measurement uncertainty ranging from a maximum standard deviation of 4.7% pre and 5.5% post respectively, indicating that the low temperature sterilisation process does not damage the sensor or reduce performance. Subsequently, an LDR brachytherapy plan reconstructed using the VariSeed treatment planning system, in an anthropomorphic 3D printed training phantom, was used to assess the suitability of the sensor for applications in LDR brachytherapy. This phantom was printed based on patient anatomy, with the volume and dimensions of the prostate designed to represent that of the patient. I-125 brachytherapy seeds, with an average activity of 0.410 mCi, were implanted into the prostate phantom under trans-rectal ultrasound guidance; following the same techniques as employed in clinical practice by an experienced radiation oncologist. This work has demonstrated that this sensor is capable of accurately identifying when radioactive I-125 sources are introduced into the prostate via a brachytherapy needle.


  • Optical fiber dosimeter for real-time in-vivo dose monitoring during LDR brachytherapy

    by Peter Woulfe, F. J. Sullivan, W. Kam, Sinead O'Keeffe

    An optical fiber sensor for monitoring low dose radiation is presented. The sensor, based on radiation sensitive scintillation material, terbium doped gadolinium oxysulphide (Gd2O2S:Tb), is embedded in a cavity of 700µm diameter within a 1mm plastic optical fiber. The sensor is compared with the treatment planning system for repeatability, angular dependency, distance and accumulated radiation activity. The sensor demonstrates a high sensitivity of 152 photon counts/Gy with a temporal resolution of 0.1 seconds, with the largest repeatability error of 4.1%, to 0.361mCi of Iodine-125 the radioactive source most commonly used in LDR brachytherapy for treating prostate cancer.


  • Investigation of YAG:Ce-Based Optical Fibre Sensor for Use in Ultra-Fast External Beam Radiotherapy Dosimetry

    by Lingxia Chen, Sinead O'KEeffe, Shuilin Chen, Peter Woulfe, Sean Gillespie, Benxue Jiang, Elfed Lewis

    Radiation dosimetry plays a crucial role in the Quality Assurance (QA) in radiotherapy. To date this is limited to monitoring the overall dose over the complete beam time and so there is limited information on the actual beam quality. An optical fibre sensor is developed based on cerium doped yttrium aluminum garnet (YAG:Ce) scintillator. The temporal resolution and stability of this scintillator-based optical fibre sensor have been experimentally evaluated and directly compared with similarly fabricated sensors based on Terbium activated Gadolinium Oxysulfide (GOS:Tb) and commercial plastic scintillating fibre, BCF-12. The photon yield and repeatability of the YAG based sensor is compared in the clinical setting with the BCF-12 sensor, and both show a high stability. The coefficient of variation of the YAG sensor is 0.7 %, which is lower than the BCF sensor with a coefficient of variation of 1.4 %.


  • Characterization of a Terbium-Activated Gadolinium Oxysulfide Plastic Optical Fiber Sensor in Photons and Protons

    by Crystal Penner, Cornelia Hoehr, Sinead O'KEeffe, Peter Woulfe, Cheryl Duzenli

    A characterization study was carried out to determine if a novel, millimeter sized Terbium-activated Gadolinium Oxysulfide optical fibre detector has potential for future use in proton dosimetry. Preliminary studies employed a Theratronics Theratron 780C Cobalt-60 unit and were used to determine nominal dose response, field size response and Čerenkov contributions in 1.25-MeV gamma radiation. More extensive testing was done using 74 MeV-protons produced in the TRIUMF 500-MeV cyclotron facility examining raw Bragg peak, spread out Bragg peak, dose response, and Čerenkov signal. The detector was low-cost and easily assembled; it showed excellent sensitivity, signal to noise ratio, and reproducibility. Quenching at high linear energy transfer was severe. Additional investigations are needed to further explore Čerenkov-only depth-dose curves, signal detection at the extreme distal end of the Bragg peak, and possible sensitivity to neutrons.


  • Open Access

    Optical fibre sensors: their role in in vivo dosimetry for prostate cancer radiotherapy

    by P. Woulfe, F. J. Sullivan, S. O’kEeffe

    Review is made of dosimetric studies of current optical fibre technology in radiotherapy for therapeutic applications, focusing particularly on in vivo dosimetry for prostate radiotherapy. We present the various sensor designs along with the main advantages and disadvantages associated with this technology. Optical fibres are ideally placed for applications in radiotherapy dosimetry; due to their small size they are lightweight and immune to electromagnetic interferences. The small dimensions of optical fibres allows it to be easily guided within existing brachytherapy equipment; for example, within the seed implantation needle for direct tumour dose analysis, in the urinary catheter to monitor urethral dose, or within the biopsy needle holder of the transrectal ultrasound probe to monitor rectal wall dose. The article presents the range of optical fibre dosimeter designs along with the main dosimetric properties required for a modern in vivo dosimetry system to be utilised in a clinical environment.


  • Open Access

    A review of recent advances in optical fibre sensors forin vivodosimetry during radiotherapy

    by S O'KEeffe, D McCarthy, P Woulfe, M W D Grattan, A R Hounsell, D Sporea, L Mihai, I Vata, G Leen, E Lewis

    This article presents an overview of the recent developments and requirements in radiotherapy dosimetry, with particular emphasis on the development of optical fibre dosemeters for radiotherapy applications, focusing particularly on in vivo applications. Optical fibres offer considerable advantages over conventional techniques for radiotherapy dosimetry, owing to their small size, immunity to electromagnetic interferences, and suitability for remote monitoring and multiplexing. The small dimensions of optical fibre-based dosemeters, together with being lightweight and flexible, mean that they are minimally invasive and thus particularly suited to in vivo dosimetry. This means that the sensor can be placed directly inside a patient, for example, for brachytherapy treatments, the optical fibres could be placed in the tumour itself or into nearby critical tissues requiring monitoring, via the same applicators or needles used for the treatment delivery thereby providing real-time dosimetric information. The a...


  • Scintillating optical fibre sensor for radiotherapy dosimetry

    by D. McCarthy, S. O'Keeffe, P. Woulfe, J. Cronin, E. Lewis

    An optical fibre sensor for monitoring low dose radiation is presented. The sensor is based on a scintillation material coated optical fibre, which emits visible light when exposed to low level ionising radiation. The incident level of ionising radiation can be determined by analysing the observed emission spectra. The work presented reports on the design of the sensor and the stability of the sensor during measurement of incident x-ray energy. Initial testing of the sensor at the radiotherapy facility at the Galway Private Clinic is presented, demonstrating the suitability of such a sensor for a range of radiotherapy dosimetry applications.